Pathology: time for digital transformation?
In essence, the approach to pathology has remained unchanged for years – but is it time for pathologists to experience digital transformation powered by AI?
In essence, the approach to pathology has remained unchanged for years – but is it time for pathologists to experience digital transformation powered by AI?
The ambition to reduce or eliminate single-use plastics from the world’s supply chains is of course as laudable as it is essential. A team at CC is dedicated to doing something about it – by creating a guide to help innovators switch to alternatives
Regulatory approval for ophthalmic combination products is like gold dust. This instalment in our ophthalmology series walks you through the challenges and helps plot a route to market
Advances in drug delivery medical devices has remained constant for 30 years. But now, we are entering an exciting new era of innovation with a new generation of miniature active implantable medical devices (AIMDs) for drug delivery.
Scale-down models have become an increasingly common development tool, especially in the bioprocessing industry. Read our eBook to discover our approach to the challenge of scaling up scale-down models.